Clinical Trial Update: Abemaciclib in Newly Diagnosed Meningioma Patients [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 study of abemaciclib in newly diagnosed meningioma patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Nader Sanai | Conditions: Meningioma | Phase 2 | Status: RECRUITING